Long-term prognosis in recipients of implantable cardioverter- defibrillators for secondary preventions in Taiwan - A multicenter registry study

Keyphrases

• All-cause Mortality 25%
• Annual Mortality Rate 25%
• Cardioverter-defibrillator Implantation 50%
• Clinical Endpoints 25%
• Consecutive Patients 25%
• Follow-up Interval 25%
• General Hospital 25%
• High Mortality Rate 25%
• History of Diabetes 50%
• Implantable Defibrillator 100%
• In(III) 25%
• Ischemic Cardiomyopathy 25%
• Kaohsiung 25%
• Left Ventricular Ejection Fraction 75%
• Life-threatening 25%
• Long-term Predictors 25%
• Long-term Prognosis 100%
• Medical Center 50%
• Mortality Prediction 100%
• Multicenter Registry 100%
• Old Age 50%
• Optimal Cutoff 25%
• Patient Selection 25%
• Receiver Operating Characteristic Curve 25%
• Registry Study 100%
• Secondary Prevention 100%
• Significant Predictors 50%
• Structural Heart Disease 50%
• Sudden Cardiac Death 25%
• Survival Duration 25%
• Taichung 25%
• Taipei 25%
• Taiwan 100%
• Type 1 Diabetes Mellitus (T1DM) 50%
• Ventricular Arrhythmia 25%

Pharmacology, Toxicology and Pharmaceutical Science

• All Cause Mortality 50%
• Cardiovascular Disease 100%
• Diabetes Mellitus 100%
• Disease 50%
• Heart Ventricle Tachycardia 50%
• Ischemic Cardiomyopathy 50%
• Mortality Rate 100%
• Sudden Cardiac Death 50%

Medicine and Dentistry

• All Cause Mortality 16%
• Clinical Endpoint 16%
• Diabetes Mellitus 33%
• Disease 16%
• Heart Disease 33%
• Heart Left Ventricle Ejection Fraction 50%
• Implantable Automatic Defibrillator 100%
• Ischemic Cardiomyopathy 16%
• Mortality Rate 33%
• Secondary Prevention 100%
• Senescence 33%
• Sudden Cardiac Death 16%
• Ventricular Tachycardia 16%